查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1537599

全球碘市场：市场占有率分析、产业趋势/统计、成长预测（2024-2029）

Iodine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2024年全球碘市场规模为40.64千吨，预计2029年将达到53.06千吨，在预测期间（2024-2029年）复合年增长率为5.48%。

碘市场

主要亮点

  • 短期内，碘需求预计将受到X射线显影剂需求增加以及碘缺乏增加导致的碘摄取需求增加的推动。
  • 然而，过量摄取导致的碘毒性和健康相关问题是研究市场成长的主要限制因素。
  • 另一方面，对除生物剂的需求不断增长以及对碘回收的需求不断增长可能会在未来几年创造利润丰厚的市场机会。
  • 欧洲已成为最大的碘市场，而亚太地区预计在 2024 年至 2029 年期间将呈现最高的复合年增长率。

碘市场趋势

医疗领域预计将主导市场

  • 碘是医疗产业的重要元素，在诊断和治疗方面有多种用途。最常见的用途是生产防腐剂和消毒剂，碘具有杀死细菌、病毒和真菌的能力，使其成为预防感染疾病的有效工具。
  • 此外，碘也用于製造用于医学影像处理（如电脑断层扫描、X 光和血管造影术）的放射性显影剂。这些材料含有碘原子，可以吸收 X 射线，使身体的内部结构在生成的图像中可见。
  • 碘原子序数大、毒性低、易于与有机化合物缀合，因此随着X射线显影剂需求的增加，其需求量也随之增加。
  • 对于在市政水处理不可靠的地区旅行或工作的人来说，碘是一种简单、有效且经济高效的水消毒方法。在对饮用水进行消毒时，在紧急情况下和旅行者中通常会使用锭剂和溶液形式的碘。近年来，随着出行人数的增加，作为消毒剂的碘的需求量也随之增加。
  • 2024年1月，据马里兰大学医学院称，在一项由马里兰大学医学院研究人员共同主导的大型多中心临床试验中，一种含碘消毒剂（酒精中的Iodine Povacrilex）经常被发现与使用的另一种皮肤消毒剂相比，四肢骨折患者的术后感染疾病减少了约四分之一。
  • 2024年1月，中国核能工业集团公司（CNNC）开始建造强大的溶液型医用同位素试验堆。该计划将生产碘 131 和碘 125 等医用同位素。医用同位素是用于医疗目的的典型放射性同位素。例如，碘 131 用于放射治疗和诊断成像。它也用于破坏功能障碍的甲状腺组织和许多其他医疗用途。根据中核集团介绍，核子反应炉建成后，碘131年产能将达到2万居里，超过目前国内需求。
  • 根据Astra Zeneca预计，2024年北美药品销售额预计将达6,330亿美元，位居第一，欧盟（不包括英国）以2,870亿美元位居第二，东南亚和东亚则以232美元位居第二。此外，2020年药品总支出为12,652亿美元，预计2025年收益为15,950亿美元。
  • 因此，由于上述因素，医疗终端用户产业预计将在2024-2029年期间主导碘市场。

预计欧洲将主导市场

  • 预计2024年至2029年欧洲将主导碘市场。德国、英国和义大利等国家的动物饲料、医疗和除生物剂应用对碘的需求不断增加。
  • 根据德国动物饲料协会（DVT）的数据，2023日历年德国饲料产量为2,170万吨（mmt），约36万吨（mt），比前12个月下降1.6%。 DVT主席宣布，与前一年同期比较意味着德国饲料产业长期萎缩的局面得到部分缓解。国内饲料产量下降的主要原因是生猪饲料销量下降。 2023 年该产业的产量将减少约 50 万吨（5.8%）至 800 万吨。
  • 此外，德国的污水再处理和回收率是欧洲最高的。 96%以上的家庭和公共设施污水排放至附近污水处理厂处理。随着该国废水处理量的增加，预计这些工厂将在 2024 年至 2029 年间使用大量碘基除生物剂。
  • 医疗产业是碘的最大消费产业。英国製药工业协会2023年12月公布的资料显示，英国生命科学产业2022年销售额将为1,081亿欧元（1,154亿美元），比2022年的959亿欧元（1,023.7亿美元）成长13 %。自2013年以来，销售额一直呈现成长趋势，但2021年至2022年成长迅速。生物製药的核心细分市场销售额最高，占生命科学产业总销售额的43%。其次是生物製药服务和供应部门以及医疗技术核心部门，各占 2022 年销售额的 25%。这些趋势也会影响碘的消费量。
  • 义大利製药业拥有庞大且可靠的製造基地，拥有约 67,000 名敬业的员工队伍。它技术先进，不仅在欧洲而且在世界上都处于主导地位。
  • 根据Farmindustria-Prometeia 2023的调查资料，义大利製药业是义大利经济的驱动力。 2023年，产业价值将达到500亿欧元（553亿美元）。义大利药品生产在欧洲製药业中扮演重要角色。根据 Farmindustria-Prometeia 2023 研究，该产业的产量在 2023 年比 2022 年增加了 7.3%。
  • 由于上述因素，预计2024年至2029年欧洲碘市场将大幅成长。

碘业概况

碘市场本质上是部分一体化的。市场主要参与者（排名不分先后）包括 SQM SA、ISE CHEMICALS CORPORATION、Cosayach、Iochem Corporation、Algorta Norte 等。

其他好处：

  • Excel 格式的市场预测 (ME) 表
  • 3 个月分析师支持

目录

第一章简介

  • 调查先决条件
  • 调查范围

第二章调查方法

第三章执行摘要

第四章市场动态

  • 促进因素
    • X射线显影剂需求增加
    • 碘缺乏症增加
  • 抑制因素
    • 碘毒性和健康问题
  • 价值链分析
  • 波特五力分析
    • 供应商的议价能力
    • 买方议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争程度

第五章市场区隔（基于数量的市场规模）

  • 来源
    • 地下卤水
    • 卡利甚矿石
    • 回收
    • 海藻
  • 形式
    • 无机盐和错合
    • 有机化合物
    • 元素和同位素
  • 目的
    • 餵食
    • 医疗保健
    • 除生物剂
    • 光学偏光片
    • 氟化学
    • 尼龙
    • 其他用途
  • 地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 义大利
      • 法国
      • 其他欧洲国家
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地区
    • 中东/非洲
      • 沙乌地阿拉伯
      • 南非
      • 其他中东/非洲

第六章 竞争状况

  • 併购、合资、联盟、协议
  • 市场占有率(%)分析
  • 主要企业策略
  • 公司简介
    • Algorta Norte
    • Calibre Chemicals Pvt. Ltd
    • Cosayach
    • Deep Water Chemicals
    • Eskay Iodine
    • Glide Chem Private Limited
    • Godo Shigen Co. Ltd
    • Iochem Corporation
    • Iofina
    • ISE Chemicals Corporation
    • Itochu Chemical Frontier Corporation
    • K&O Energy Group Inc.
    • Nippoh Chemicals Co. Ltd
    • Parad Corporation Pvt. Ltd
    • Proto Chemical Industries
    • Salvi Chemical Industries Ltd
    • Samrat Pharmachem Limited
    • SQM SA
    • TOHO Earthtech Inc.

第七章 市场机会及未来趋势

  • 碘回收需求不断增加
  • 增加除生物剂的使用
简介目录
Product Code: 69271

The Iodine Market size is estimated at 40.64 kilotons in 2024, and is expected to reach 53.06 kilotons by 2029, growing at a CAGR of 5.48% during the forecast period (2024-2029).

Iodine - Market

Key Highlights

  • In the short term, the increasing demand for X-ray contrast media and increasing requirements for iodine uptake with growing iodine deficiency among people are expected to drive the demand for iodine.
  • However, the toxicity of iodine and health-related issues due to excessive consumption pose major restraints to the studied market growth.
  • On the other hand, the rising demand for biocides and the growing demand for recycling iodine are likely to create lucrative market opportunities in the coming years.
  • Europe emerged as the largest market for iodine, while Asia-Pacific is expected to witness the highest CAGR between 2024 and 2029.

Iodine Market Trends

The Medical Segment is Expected to Dominate the Market

  • Iodine is a crucial element in the medical industry, with many applications in diagnosis and treatment. Its most common use is in producing antiseptics and disinfectants, where iodine's ability to kill bacteria, viruses, and fungi makes it an effective tool for preventing infections.
  • In addition, iodine is used to produce radiocontrast materials, which are used in medical imaging procedures such as CT scans, X-rays, and angiograms. These materials contain iodine atoms, which absorb X-rays and make the internal structures of the body visible in the resulting images.
  • The demand for iodine has been increasing over the rising need for X-ray contrast media because of its high atomic number, low toxicity, and ease of adjunction with organic compounds.
  • Iodine is a simple, effective, and cost-efficient means of water disinfection for people who travel or work in areas where municipal water treatment is unreliable. In terms of the disinfection of drinking water, iodine is commonly used in the form of tablets or solutions during emergencies and by travelers. As the number of travelers has increased in recent years, the demand for iodine as a disinfectant has also been increasing.
  • In January 2024, according to the University of Maryland School of Medicine, a large multicenter clinical trial co-led by the University of Maryland School of Medicine researchers found that an antiseptic containing iodine (iodine povacrylex in alcohol) resulted in about one-quarter fewer post-surgical infections in patients with limb fractures compared to another frequently used skin antiseptic.
  • In January 2024, China National Nuclear Corporation (CNNC) started the construction of a powerful solution-type medical isotope test reactor. This initiative will produce Iodine-131 and iodine-125, among other medical isotopes. Medical isotopes are typical radioactive isotopes that are used for medical purposes. For example, iodine-131 is used for radiotherapy or imaging. It can also be used to destroy dysfunctional thyroid tissues and many other medical applications. According to CNNC, after completing the medical isotope reactor, which is estimated to be completed by 2027, it will attain an annual production capacity of 20,000 curies of iodine-131, surpassing the current domestic demand.
  • According to AstraZeneca, the projected pharmaceutical sales in 2024 are expected to be USD 633 billion for North America, holding the major share, followed by the European Union (excluding the United Kingdom) with USD 287 billion at the second position, followed by Southeast and East Asia and expected to register USD 232 billion. Also, the total spending on medicines in 2020 was USD 1,265.2 billion, which is expected to generate a revenue of USD 1,595 billion in 2025.
  • Hence, owing to the above-mentioned factors, the medical end-user industry is expected to dominate the market for iodine from 2024 to 2029.

Europe is Expected to Dominate the Market

  • Europe is expected to dominate the iodine market between 2024 and 2029. Countries like Germany, the United Kingdom, and Italy are seeing rising demand for iodine in animal feed, medical, and biocide applications.
  • According to the German Animal Feed Association (DVT), at 21.7 million metric tons (mmt), feed production in Germany in the 2023 calendar year was around 360,000 metric tons (mt), or 1.6% less than in the previous 12 months. The DVT President announced that the year-on-year contraction represents a partial easing in the long-term contraction in the German feed sector. The decline in total national feed output is attributed mainly to reduced sales of pig feeds. This segment's production was down approximately 500,000 mt or 5.8% to 8 mmt for 2023.
  • Moreover, Germany has the highest wastewater reprocessing and recycling rate in Europe. More than 96% of the wastewater from private households or public facilities is discharged into nearby sewage treatment plants for processing. With the country's increasing sewage water volume, these plants are expected to exploit a larger volume of iodine-based biocides between 2024 and 2029.
  • The medical industry is the largest consumer of iodine. According to data from the Association of the British Pharmaceutical Industry released in December 2023, businesses in the UK life sciences industry generated EUR 108.1 billion (USD 115.4 billion) in turnover in 2022, a 13% increase from the EUR 95.9 billion (USD 102.37 billion) turnover in 2022. Turnover has seen an upward trend since 2013 but increased sharply between 2021 and 2022. The sector that generated the highest turnover was the biopharmaceutical core sector, accounting for 43% of the total turnover generated across the life sciences industry. This was followed by the biopharmaceutical service and supply and medical technology core sectors, each accounting for 25% of turnover in 2022. Such trends affect the consumption of iodine.
  • The Italian pharmaceutical industry represents a vast and reliable manufacturing base with a dedicated workforce of around 67,000 people. It is technologically advanced and has a strong leadership position in Europe and beyond.
  • According to the data from the Farmindustria-Prometeia 2023 survey, the Italian pharmaceutical industry is the driving force of the country's economy. In 2023, the industry value reached EUR 50 billion (USD 55.3 billion). The Italian pharmaceutical production plays a vital role in Europe's pharmaceutical industry. The sector's output increased by 7.3% in 2023 compared to 2022, according to the Farmindustria-Prometeia 2023 survey.
  • Owing to the factors mentioned above, the market for iodine in Europe is projected to grow significantly between 2024 and 2029.

Iodine Industry Overview

The iodine market is partially consolidated in nature. Some of the major players in the market (not in any particular order) are SQM SA, ISE CHEMICALS CORPORATION, Cosayach, Iochem Corporation, and Algorta Norte.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Increasing Demand in X-ray Contrast Media
    • 4.1.2 Growing Iodine Deficiency Among People
  • 4.2 Restraints
    • 4.2.1 Toxicity of Iodine and Health-related Issues
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Volume)

  • 5.1 Source
    • 5.1.1 Underground Brine
    • 5.1.2 Caliche Ore
    • 5.1.3 Recycling
    • 5.1.4 Seaweeds
  • 5.2 Form
    • 5.2.1 Inorganic Salts and Complexes
    • 5.2.2 Organic Compounds
    • 5.2.3 Elementals and Isotopes
  • 5.3 Application
    • 5.3.1 Animal Feed
    • 5.3.2 Medical
    • 5.3.3 Biocides
    • 5.3.4 Optical Polarizing Films
    • 5.3.5 Fluorochemicals
    • 5.3.6 Nylon
    • 5.3.7 Other Applications
  • 5.4 Geography
    • 5.4.1 Asia-Pacific
      • 5.4.1.1 China
      • 5.4.1.2 India
      • 5.4.1.3 Japan
      • 5.4.1.4 South Korea
      • 5.4.1.5 Rest of Asia-Pacific
    • 5.4.2 North America
      • 5.4.2.1 United States
      • 5.4.2.2 Canada
      • 5.4.2.3 Mexico
    • 5.4.3 Europe
      • 5.4.3.1 Germany
      • 5.4.3.2 United Kingdom
      • 5.4.3.3 Italy
      • 5.4.3.4 France
      • 5.4.3.5 Rest of Europe
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 South Africa
      • 5.4.5.3 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers And Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share (%) Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Algorta Norte
    • 6.4.2 Calibre Chemicals Pvt. Ltd
    • 6.4.3 Cosayach
    • 6.4.4 Deep Water Chemicals
    • 6.4.5 Eskay Iodine
    • 6.4.6 Glide Chem Private Limited
    • 6.4.7 Godo Shigen Co. Ltd
    • 6.4.8 Iochem Corporation
    • 6.4.9 Iofina
    • 6.4.10 ISE Chemicals Corporation
    • 6.4.11 Itochu Chemical Frontier Corporation
    • 6.4.12 K&O Energy Group Inc.
    • 6.4.13 Nippoh Chemicals Co. Ltd
    • 6.4.14 Parad Corporation Pvt. Ltd
    • 6.4.15 Proto Chemical Industries
    • 6.4.16 Salvi Chemical Industries Ltd
    • 6.4.17 Samrat Pharmachem Limited
    • 6.4.18 SQM SA
    • 6.4.19 TOHO Earthtech Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Increasing Demand for Recycling Iodine
  • 7.2 Rise in the Usage of Biocides